Phenelzine treatment of selective mutism in four prepubertal children

Journal of Child and Adolescent Psychopharmacology

Volumn 9, Issue 2, 1999, Pages 109-113

  Golwyn, Daniel H ^a   Sevlie, Carol P ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENELZINE;

ARTICLE; CASE REPORT; CHILD; CHILD PSYCHIATRY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MUTISM; OBESITY; PREPUBERTY; WEIGHT GAIN;

EID: 0032799713     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.1999.9.109     Document Type: Article

References (19)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC, American Psychiatric Association, 1987
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC, American Psychiatric Association, 1994
3. Black B, Uhde TW: Treatment of elective mutism with fluoxetine: A double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 33:1000-1006, 1994
4. Dummit ES, Klein RG, Tancer NK, Asche B, Martin J: Fluoxetine treatment of children with selective mutism: An open trial. J Am Acad Child Adolesc Psychiatry 35:615-621, 1996
5. Dummit ES, Klein RG, Tancer NK, Asche B, Martin J, Fairbanks JA: Systematic assessment of 50 children with selective mutism. J Am Acad Child Adolesc Psychiatry 36:653-660, 1997
6. Glue P, Coupland N, Nutt DJ: Pharmacological basis for the therapeutic activity of MAOIs. In: Clinical Advances in Monoamine Oxidase Inhibitor Therapies. Edited by Kennedy SH. Washington, DC, American Psychiatric Press Inc., 1994, pp 1-31
7. Golwyn DH, Sevlie C: Monoamine oxidase inhibitor hypertensive crisis headache and orthostatic hypotension [letter]. J Clin Psychopharmacol 13:77-78, 1993
8. Golwyn DH, Sevlie C: Monoamine oxidase inhibitor hypertensive crisis headache: Prevention and treatment. Headache Quarterly 7:207-214, 1996
9. Golwyn DH, Weinstock RC: Phenelzine treatment of elective mutism: A case report. J Clin Psychiatry 51:384-385, 1990
10. Kelly D, Guirguis W, Frommer E, Mitchell-Heggs N, Sargant W: Treatment of phobic states with antidepressants. A retrospective study of 246 patients. Br J Psychiatry 116:387-398, 1970
11. Leonard HL, Dow S: Selective mutism. In: Anxiety Disorders in Children and Adolescents. Edited by March JS. New York, Guilford Press, 1995, pp 235-250
12. Leonard HL, Topol DA: Elective mutism. Child Adolesc Psychiatr Clin North Am 2:695-707, 1993
13. Liebowitz MR, Campeas R, Hollander E: MAOIs: Impact on social behavior [letter]. Psychiatry Res 22:89-90, 1987
14. Liebowitz MR, Gorman JM, Fyer AJ, Campeas R, Levin AP, Sandberg D, Hollander E, Papp L, Goetz, D: Pharmacotherapy of social phobia. An interim report of a placebo-controlled comparison of phenelzine and atenolol. J Clin Psychiatry 49:252-257, 1988
15. Lesser-Katz M: Stranger reaction and elective mutism in young children. Am J Orthopsychiatry 56:458-469, 1986
16. Tiihonen J, Kuikka J, Bergstrom K, Lepola U, Koponen H, Leinonen E: Dopamine reuptake site densities in patients with social phobia. Am J Psychiatry 154:239-242, 1997
17. Versiani M, Nardi AE, Mundim FD, Alves AB, Liebowitz MR, Amrein R: Pharmacotherapy of social phobia: A controlled study with moclobemide and phenelzine. Br J Psychiatry 161:353-360, 1992
18. Wilkins R: A comparison of elective mutism and emotional disorders in children. BrJ Psychiatry 146:198-203, 1985
19. Zametkin A, Rapoport JL, Murphy DL, Linnoila M, Ismond D: Treatment of hyperactive children with monoamine oxidase inhibitors, I: Clinical efficacy. Arch Gen Psychiatry 42:962-966, 1985